Terveystalo Oyj — Proxy Solicitation & Information Statement 2026

Feb 27, 2026

Notice to the Annual General Meeting

Notice to the Annual General Meeting

Notice is given to the shareholders of Terveystalo Plc (the “Company”) to
participate in the Annual General Meeting to be held on Tuesday, 24 March 2026
at 10:00 a.m. (EET) at Kulttuurikasarmi (in between Lasipalatsi and Kamppi
Center) at the address Narinkka 2, 00100 Helsinki, Finland. The reception of
participants and the distribution of voting tickets will commence at the meeting
venue at 9:00 a.m. (EET).

Shareholders and their proxy representatives may also exercise their voting
rights by voting in advance. Instructions for advance voting are presented in
this notice under section C “Instructions for the participants in the Annual
General Meeting”.

A. Matters on the agenda of the Annual General Meeting

The following matters will be considered at the Annual General Meeting:

1. Opening of the meeting

2. Calling the meeting to order

3. Election of the persons to scrutinize the minutes and to verify the counting
   of votes

4. Recording of the legality of the meeting

5. Recording the attendance at the meeting and adoption of the list of votes

6. Presentation of the Financial Statements, the Report of the Board of
   Directors, the Auditor's Report and the Sustainability Reporting Assurance
   Report for the year 2025

Review by the CEO.

The Financial Statements, the Report of the Board of Directors, the Auditor's
Report and the Sustainability Reporting Assurance Report are available on the
Company's website at https://www.terveystalo.com/Annual-General-Meeting-2026.

1. Adoption of the Financial Statements

The Board of Directors proposes that the Annual General Meeting adopt the
Financial Statements for 2025.

1. Resolution on the use of the profit shown on the balance sheet and
   distribution of dividend

The parent company's distributable funds totalled EUR 582.1 (558.9) million, of
which EUR 83.9 (61.0) million is result for the financial year. The Board of
Directors proposes to the Annual General Meeting that a dividend of EUR 0.64
(0.48) per share be paid based on the balance sheet adopted for the financial
year ended 31 December 2025 (which corresponds to a total of approximately EUR
81.1 (60.8) million with the current number of shares in the Company).

The dividend would be paid in two instalments as follows:

· The first dividend instalment of EUR 0.32 per share would be paid to
shareholders who are entered in the shareholders' register of the Company
maintained by Euroclear Finland Oy on the record date of the first dividend
instalment 26 March 2026. The Board of Directors proposes that the first
dividend instalment would be paid on 8 April 2026.

· The second dividend instalment of EUR 0.32 per share would be paid to
shareholders who are entered in the shareholders' register of the Company
maintained by Euroclear Finland Oy on the record date of the second dividend
instalment 8 October 2026. The Board of Directors proposes that the second
dividend instalment would be paid on 15 October 2026. The Board of Directors
also proposes that the Annual General Meeting would authorize the Board of
Directors to resolve, if necessary, on a new record date and date of payment for
the second dividend instalment should the rules of Euroclear Finland Oy or
statutes applicable to the Finnish book-entry system change or otherwise so
require.

1. Resolution on the discharge of the members of the Board of Directors and the
   CEO from liability for the financial year 1 January 2025 - 31 December 2025

2. Handling of the Remuneration Report for governing bodies

The Board of Directors proposes that the Annual General Meeting approve the 2025
Remuneration Report for governing bodies. The Annual General Meeting's
resolution on the approval of the Remuneration Report is advisory.

The Remuneration Report for the Company's governing bodies is available on the
Company's website at https://www.terveystalo.com/Annual-General-Meeting-2026.

1. Resolution on the remuneration of the members of the Board of Directors

The Shareholders' Nomination Board proposes to the Annual General Meeting that
remuneration be increased moderately and that the following remuneration be paid
to the members of the Board during the next term:

· Annual remuneration of the Chairman EUR 94,300
· Annual remuneration of the Vice-Chairman EUR 55,400
· Annual remuneration of the members EUR 44,300
· Annual remuneration of the Chairman of the Audit Committee EUR 55,400.

Additionally, the following attendance fees shall be paid for each Board and
Committee meeting: EUR 700 for members residing in Finland, EUR 1,455 for
members residing elsewhere in Europe, and EUR 2,910 for members residing outside
of Europe. For Board and Committee meetings that are held by telephone or other
electronic means, the attendance fee shall be EUR 700. Travel expenses and other
costs directly related to Board work are proposed to be reimbursed in accordance
with the Company's policy.

In addition, the Shareholders' Nomination Board proposes the annual remuneration
of the Board of Directors to be paid as a combination of Company shares and cash
in such a manner that 40 per cent of the annual remuneration is paid in the
Company's shares, which will be purchased from the market on behalf of the
members of the Board of Directors at a price determined in public trading, and
60 per cent is paid in cash. The Company will reimburse the transaction costs
and transfer tax in connection with the purchase of the remuneration shares. The
shares will be purchased within a period of two weeks beginning from the date
following the publication of the quarterly result for the period 1 July -
30 September 2026. Attendance fees are proposed to be paid in cash.

1. Resolution on the number of members of the Board of Directors

The Shareholders' Nomination Board proposes to the Annual General Meeting that
the number of members of the Board of Directors be six (6).

1. Election of the members of the Board of Directors

The Shareholders' Nomination Board proposes to the Annual General Meeting, for a
term that ends at the end of the Annual General Meeting 2027, that Kari
Kauniskangas, Sofia Hasselberg, Ari Lehtoranta and Teija Sarajärvi are re
-elected as members of the Board of Directors and Nathalie Ahlström and Petri
Castrén are elected as new members of the Board of Directors.

Carola Lemne, Kristian Pullola and Matts Rosenberg have announced that they will
not be available for re-election.

The Shareholders' Nomination Board recommends that Kari Kauniskangas be re
-elected as the Chairman of the Board of Directors.

All candidates have given their consent to the position and the Shareholders'
Nomination Board has assessed all candidates to be independent of the Company
and of major shareholders. The curricula vitae of the proposed new members of
the Board of Directors, Nathalie Ahlström and Petri Castrén, are available on
the Company's website at https://www.terveystalo.com/Annual-General-Meeting
-2026. The biographical details of the members of the Board of Directors
proposed for re-election can be found at the Company website:
https://www.terveystalo.com/en/company/investors/corporate-governance/board-of
-directors.

1. Amendment of the Articles of Association

The Board of Directors proposes to the Annual General Meeting that the Annual
General Meeting resolve to amend Sections 9 § and 12 § (current Section 11 §) of
the Company's Articles of Association to read in their entirety as set out below
(amended parts have been underlined), to add a new Section 10 § as set out
below, and to update the numbering of current Sections 10 § and 11 §
correspondingly. The purpose of the proposed amendments concerning the term of
office of the auditor is to enable the election of the auditor more flexibly
than currently, also for a term of office commencing later, as proposed in item
17 of this notice to the Annual General Meeting. In other respects, the purpose
is to update the Articles of Association to better reflect the currently
applicable regulations and to define the term of office of the sustainability
reporting assurance provider correspondingly with the auditor.

"9 § The General Meeting shall elect for each term of office one (1) auditor to
examine the administration and accounts of the Company. The auditor shall be an
audit firm authorised by the Finnish Patent and Registration Office with an
authorised public accountant in charge of the audit.

An auditor may be elected for a term of office that commences at the close of
the General Meeting resolving on the election or for a term of office commencing
later in accordance with the resolution of the General Meeting. The auditor's
term of office shall end at the closing of the next Annual General Meeting
following the commencement of the term."

"10 § As the Company's sustainability reporting assurance provider for each term
of office, the General Meeting shall elect one (1) authorized sustainability
audit firm, with an Authorized Sustainability Auditor as referred to in the
Finnish Auditing Act as the principally responsible sustainability reporting
assurance provider. The Company's auditor with a special qualification as an
Authorized Sustainability Auditor can also be elected for this position.

A sustainability reporting assurance provider may be elected for a term of
office that commences at the close of the General Meeting resolving on the
election or for a term of office commencing later in accordance with the
resolution of the General Meeting. The sustainability reporting assurance
provider's term of office shall end at the closing of the next Annual General
Meeting following the commencement of the term."

--

"12 § At the Annual General Meeting, the following shall be

presented:

1. the financial statements, which encompasses the consolidated financial
   statements, and

2. the auditor's report;

decided upon:

1. the adoption of the financial statements,
2. the use of the profit shown on the balance sheet,

3. the discharge of the members of the Board of Directors and the Managing
   Director from liability,

4. if necessary, the remuneration policy,

5. the approval of the remuneration report,

6. the remuneration of the members of the Board of Directors and, if necessary,
   of the auditor and the sustainability reporting assurance provider, and
7. the number of the members of the Board of Directors;

elected:
10. the members of the Board of Directors,
11. the auditor, if necessary, and

1. the sustainability reporting assurance provider, if necessary; and

addressed:
13. other issues possibly indicated in the notice of the meeting."

1. Resolution on the remuneration of the auditor for the terms of office 2026
   and 2027

The Board of Directors proposes to the Annual General Meeting, based on the
recommendation of the Audit Committee, that the auditor's fee for the auditors
to be elected under items 16 and 17, respectively, be paid against an invoice
approved by the Company.

1. Election of the auditor for the term of office 2026

The Board of Directors proposes to the Annual General Meeting, based on the
recommendation of the Audit Committee, that KPMG Oy Ab, a firm of authorized
public accountants, be elected as the auditor of the Company for the term of
office ending at the end of the Annual General Meeting 2027. KPMG Oy Ab has
announced that Henrik Holmbom, APA, would be acting as the principally
responsible auditor.

The proposal of the Board of Directors including the recommendation of the Audit
Committee is available on the Company's website at
https://www.terveystalo.com/Annual-General-Meeting-2026.

17. Election of the auditor for the term of office 2027

The Company has an obligation to organize an audit firm selection procedure in
accordance with the EU Audit Regulation (537/2014, as amended) concerning the
audit for the financial year 2027 (mandatory auditor rotation). As the EU Audit
Regulation requires the inclusion of at least two candidates in the
recommendation of the Audit Committee and the candidates' possibilities to
provide services to the Company until the General Meeting deciding on the
election are restricted, the Board of Directors proposes that the auditor would
be elected for the term of office 2027 already in this Annual General Meeting
2026. The election of an auditor for the term of office 2027 already in this
Annual General Meeting also provides the elected audit firm time to prepare for
the new audit engagement and ensures the opportunity of the General Meeting to
influence the selection.

In view of the above, the Board of Directors proposes to the Annual General
Meeting, based on the recommendation of the Audit Committee, that KPMG Oy Ab, a
firm of authorized public accountants, be elected as the auditor of the Company
for the term of office commencing at the end of the Annual General Meeting 2027
and ending at the end of the Annual General Meeting 2028. KPMG Oy Ab has
announced that Heli Tuuri, APA, would be acting as the principally responsible
auditor.

The proposal of the Board of Directors and the recommendation of the Audit
Committee are available on the Company's website at
https://www.terveystalo.com/Annual-General-Meeting-2026.

The proposal concerning the election of the auditor for the term of office 2027
is conditional upon the General Meeting deciding to amend Section 9 § of the
Articles of Association in accordance with the proposal of the Board of
Directors presented above in item 14. The resolution in accordance with this
proposal concerning the election of the auditor for the term of office 2027
shall enter into force once the amended Articles of Association have been
registered in the Finnish Trade Register.

1. Resolution on the remuneration of the sustainability reporting assurance
   provider for the terms of office 2026 and 2027

The Board of Directors proposes to the Annual General Meeting, based on the
recommendation of the Audit Committee, that the sustainability reporting
assurance provider's fee for the sustainability reporting assurance providers to
be elected under items 19 and 20, respectively, be paid against an invoice
approved by the Company.

1. Election of the sustainability reporting assurance provider for the term of
   office 2026

The Board of Directors proposes to the Annual General Meeting, based on the
recommendation of the Audit Committee, that KPMG Oy Ab, an authorized
sustainability audit firm, be elected as the sustainability reporting assurance
provider of the Company for the term of office ending at the end of the Annual
General Meeting 2027. KPMG Oy Ab has announced that Henrik Holmbom, APA and
Authorized Sustainability Auditor (ASA), would be acting as the principally
responsible sustainability reporting assurance provider.

The election of KPMG Oy Ab as the sustainability reporting assurance provider of
the Company for the term of office 2026 is conditional on KPMG Oy Ab being
elected as the Company's auditor.

20. Election of the sustainability reporting assurance provider for the term of
office 2027

The Board of Directors proposes to the Annual General Meeting, based on the
recommendation of the Audit Committee, that KPMG Oy Ab, an authorized
sustainability audit firm, be elected as the sustainability reporting assurance
provider of the Company for the term of office commencing at the end of the
Annual General Meeting 2027 and ending at the end of the Annual General Meeting
2028. KPMG Oy Ab has announced that Heli Tuuri, APA and Authorized
Sustainability Auditor (ASA), would be acting as the principally responsible
sustainability reporting assurance provider.

The proposal concerning the election of KPMG Oy Ab as the sustainability
reporting assurance provider of the Company for the term of office 2027 is
conditional upon the General Meeting deciding to amend Section 9 § of the
Articles of Association and to add a new Section 10 § to the Articles of
Association in accordance with the proposal of the Board of Directors presented
above in item 14 and on KPMG Oy Ab being elected as the Company's auditor for
the term of office 2027. The resolution in accordance with this proposal
concerning the election of the sustainability reporting assurance provider for
the term of office 2027 shall enter into force once the amended Articles of
Association have been registered in the Finnish Trade Register.

1. Authorizing the Board of Directors to decide on the repurchase and/or on the
   acceptance as pledge of the Company's own shares

The Board of Directors proposes to the Annual General Meeting that the Board of
Directors be authorized to decide on the repurchase and/or on the acceptance as
pledge of the Company's own shares as follows.

The number of own shares to be repurchased shall not exceed 12,703,653 shares,
which corresponds to approximately 10 per cent of all shares in the Company.
Only the unrestricted equity of the Company can be used to repurchase own shares
on the basis of the authorization.

Own shares can be repurchased at a price formed in public trading on the date of
the repurchase or otherwise at a price formed on the market.

The Board of Directors decides how own shares will be repurchased and/or
accepted as pledge. Shares can be repurchased using, inter alia, derivatives.
Own shares can also be repurchased otherwise than in proportion to the
shareholdings of the existing shareholders (directed repurchase).

The authorization is effective until the end of the next Annual General Meeting,
however no longer than until 30 June 2027.

1. Authorizing the Board of Directors to decide on the issuance of shares and
   the issuance of special rights entitling to shares

The Board of Directors proposes to the Annual General Meeting that the Board of
Directors be authorized to decide on the issuance of shares and the issuance of
special rights entitling to shares referred to in Chapter 10, Section 1 of the
Companies Act as follows.

The number of shares to be issued under the authorization shall not exceed
12,703,653 shares, which corresponds to approximately 10 per cent of all shares
in the Company. The shares issued under the authorization may be new shares or
treasury shares held by the Company.

The Board of Directors decides on all the conditions of the issuance of shares
and of special rights entitling to shares. The issuance of shares and of special
rights entitling to shares may be carried out in deviation from the
shareholders' pre-emptive rights (directed issue).

The authorization is effective until the end of the next Annual General Meeting,
however no longer than until 30 June 2027.

1. Authorizing the Board of Directors to resolve on donations for charitable
   purposes

The Board of Directors proposes to the Annual General Meeting that the Annual
General Meeting resolve to authorize the Board of Directors to decide on
donations in a total maximum of EUR 150,000 for charitable or corresponding
purposes and to authorize the Board of Directors to decide on the donation
recipients, purposes of use and other terms of the donations. The authorization
is proposed to remain effective until the end of the Annual General Meeting 2027
and in any event no longer than for a period of 18 months from the date of the
resolution of the Annual General Meeting.

1. Closing of the meeting

B. Documents of the Annual General Meeting

The above-mentioned proposals for resolutions on the matters on the agenda of
the Annual General Meeting, this notice and the Annual Report of the Company,
which includes the Company's Financial Statements, the Report of the Board of
Directors, the Auditor's Report and the Sustainability Reporting Assurance
Report, as well as the Remuneration Report, are available on the Company's
website at https://www.terveystalo.com/Annual-General-Meeting-2026. The
proposals for resolutions and other above-mentioned documents are also available
at the Annual General Meeting. The minutes of the Annual General Meeting will be
available on the above-mentioned website on 7 April 2026 at the latest.

C. Instructions for the participants in the Annual General Meeting

1. Shareholder registered in the shareholders' register

Each shareholder, who on the record date of the Annual General Meeting, 12 March
2026, is entered in the Company's shareholders' register maintained by Euroclear
Finland Oy, has the right to participate in the Annual General Meeting. A
shareholder whose shares are registered on his/her personal Finnish book-entry
account or equity savings account is registered in the Company's shareholders'
register. A shareholder may also participate in the Annual General Meeting by
way of proxy representation or by voting in advance; the use of proxy
representatives is described below in section C.4 and advance voting is
described in section C.5.

1. Registration for the meeting

Registration for the meeting and advance voting will begin on 2 March 2026 at
10:00 a.m. (EET) and a shareholder who is registered in the Company's
shareholders' register and who wishes to participate in the Annual General
Meeting must register for the meeting and, if applicable, vote in advance no
later than by 17 March 2026 at 4:00 p.m. (EET), by which time the registration
and possible advance votes must be received by the Company or Innovatics Oy.

Shareholders with a Finnish book-entry account may register from 10:00 a.m.
(EET) on 2 March 2026 until 4:00 p.m. (EET) on 17 March 2026 by the following
manners:

a. through the Company's website at https://www.terveystalo.com/Annual-General
-Meeting-2026

Electronic registration through the website requires strong electronic
authentication of the shareholder or the shareholder's proxy representative or
legal representative with a Finnish, Swedish or Danish bank ID or mobile
certificate.

b. by email or regular mail

A shareholder may send a notice of attendance to Innovatics Oy by email
addressed to agm@innovatics.fi or by regular mail addressed to Innovatics Oy,
General Meeting/Terveystalo Oyj, Ratamestarinkatu 13 A, FI-00520 Helsinki,
Finland. A shareholder registering by mail or e-mail shall submit the
registration and advance voting form available on the Company's website at
https://www.terveystalo.com/Annual-General-Meeting-2026 or equivalent
information to Innovatics Oy (information regarding advance voting is only
required if the shareholder intends to vote in advance).

In connection with the registration, a shareholder is required to provide the
requested information, such as his/her name, date of birth or business ID,
address, as well as telephone number and/or e-mail address as well as the name,
date of birth as well as telephone number and/or e-mail address of a possible
authorized proxy representative or legal representative and the name of a
possible assistant. The personal data given to the Company or Innovatics Oy will
be used only in connection with the Annual General Meeting and with the
processing of related registrations.

A shareholder, their possible authorized proxy representative or legal
representative must be able to prove their identity and/or right of
representation at the Annual General Meeting.

Further information on registration and advance voting is available by telephone
during the registration period for the Annual General Meeting by calling
Innovatics Oy at +358 10 2818 909 on weekdays from 9:00 a.m. to 12:00 noon and
from 1:00 p.m. to 4:00 p.m. (EET).

1. Holders of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the Annual
General Meeting by virtue of such shares, based on which he/she on the record
date of the Annual General Meeting, i.e., on 12 March 2026, would be entitled to
be registered in the shareholders' register of the Company maintained by
Euroclear Finland Oy. The right to participate in the Annual General Meeting
requires, in addition, that the shareholder on the basis of such shares has been
temporarily registered into the shareholders' register maintained by Euroclear
Finland Oy at the latest by 19 March 2026 by 10.00 a.m. (EET). As regards
nominee-registered shares this constitutes registration for the Annual General
Meeting.

A holder of nominee-registered shares is advised to request without delay
necessary instructions regarding the temporary registration in the shareholders'
register of the Company, the issuing of proxy documents and voting instructions
as well as registration for the Annual General Meeting from his/her custodian
bank. The account management organization of the custodian bank shall
temporarily register a holder of nominee-registered shares, who wants to
participate in the Annual General Meeting, into the shareholders' register of
the Company at the latest by the time stated above as well as, if necessary,
arrange advance voting on behalf of the holders of nominee registered shares
before the end of the registration period for nominee-registered shares.

1. Proxy representatives and powers of attorney

A shareholder may also participate and use their rights in the Annual General
Meeting through a proxy representative. A proxy representative shall provide a
dated proxy document or otherwise in a reliable manner demonstrate his/her right
to represent the shareholder.

A proxy representative may also choose to vote in advance in the manner
described in this notice. Proxy representatives registering electronically for
the Annual General Meeting must identify themselves personally through strong
electronic authentication, after which they can register on behalf of the
shareholder they represent. The same applies to voting in advance
electronically.

Should a shareholder participate in the Annual General Meeting by means of
several proxy representatives representing the shareholder with shares in
different book-entry accounts, the shares by which each proxy representative
represents the shareholder shall be identified in connection with the
registration.

Natural persons may appoint a proxy representative in connection with the
electronic registration to the Annual General Meeting at the Company's website.
Otherwise, a proxy document must be used. A template proxy document is available
on the Company's website at https://www.terveystalo.com/Annual-General-Meeting
-2026.

Possible proxy authorization documents are requested to be submitted preferably
as attachments in connection with electronic registration or alternatively by
email to agm@innovatics.fi or as original copies by mail to Innovatics Oy,
General Meeting/Terveystalo Oyj, Ratamestarinkatu 13 A, FI-00520 Helsinki,
Finland, so that the proxy authorization documents are received before the end
of the registration and advance voting period.

In addition to delivering a proxy authorization document, a shareholder or their
proxy representative must register for the Annual General Meeting in the manner
described in section C.2. Delivering a proxy authorization document in the
manner described above will constitute due registration for the Annual General
Meeting if it contains the information required for the registration described
in section C.2.

Shareholders can also use suomi.fi electronic authorization service instead of
traditional proxy document. In this case, the shareholder authorizes the
nominated proxy representative in suomi.fi service (https://www.suomi.fi/e
-authorizations) by using the proxy form “Representation at the General
Meeting”. When registering, proxy representatives must authenticate themselves
by strong electronic authentication. Strong electronic authentication can be
conducted with online banking codes or a mobile certificate.

1. Advance voting

Shareholders with a Finnish book-entry account or equity savings account may
also vote in advance on certain agenda items of the Annual General Meeting
during the period between 2 March 2026 at 10:00 a.m. (EET) - 17 March 2026 at
4:00 p.m. (EET).

Shareholders who have voted in advance and who wish to exercise their right to
ask questions, demand a vote at the Annual General Meeting or vote on a possible
counterproposal under the Finnish Companies Act must participate in the Annual
General Meeting at the meeting venue in person or by way of proxy
representation.

For holders of nominee-registered shares, advance voting is carried out via the
account manager. The account manager may cast advance votes on behalf of the
holders of nominee-registered shares in accordance with the voting instructions
provided by the holders of nominee-registered shares during the registration
period for the nominee-registered shares.

Advance voting can be done as follows:

a. electronically on the Company's website at
https://www.terveystalo.com/Annual-General-Meeting-2026

Electronic voting in advance requires strong electronic authentication of the
shareholder or the shareholder's proxy representative or legal representative
with a Finnish, Swedish or Danish bank ID or mobile certificate.

b. by email or regular mail

A shareholder may submit the registration and advance voting form available on
the Company's website or corresponding information to Innovatics Oy by email
addressed to agm@innovatics.fi or by regular mail addressed to Innovatics Oy,
General Meeting/Terveystalo Oyj, Ratamestarinkatu 13 A, FI-00520 Helsinki,
Finland. A legal representative or authorized proxy representative of a
shareholder must in connection with delivering the registration and advance
voting form produce a dated proxy authorization document or otherwise in a
reliable manner demonstrate his/her right to represent the shareholder at the
Annual General Meeting.

If a shareholder participates in the Annual General Meeting by submitting votes
in advance to Innovatics Oy before the deadline for registration and advance
voting, the submission constitutes due registration for the Annual General
Meeting, provided that it contains the information required for registration, as
mentioned above in section C.2.

A proposal subject to advance voting is deemed to have been presented without
amendments at the Annual General Meeting.

Instructions regarding the electronic advance voting are also available on the
Company's website at https://www.terveystalo.com/Annual-General-Meeting-2026.

1. Other instructions/information

The language of the Annual General Meeting is Finnish, and the meeting will be
simultaneously translated into English. A shareholder who is present at the
Annual General Meeting has the right to request information with respect to the
matters to be considered at the Annual General Meeting in accordance with
Chapter 5 Section 25 of the Finnish Companies Act.

Information on the Annual General Meeting required by the Finnish Companies Act
and the Securities Markets Act is available on the Company's website at
https://www.terveystalo.com/Annual-General-Meeting-2026.

On the date of this notice, the total number of shares in the Company and votes
represented by such shares is 127,036,531. On the date of this notice the
Company and its subsidiaries hold a total of 381,388 of the Company's own shares
that are not entitled to vote at the Annual General Meeting.

Changes in shareholding after the record date of the Annual General Meeting do
not affect the right to participate in the Annual General Meeting or the number
of voting rights held by a shareholder in the Annual General Meeting.

It is recommended to arrive at the meeting venue using public transportation.

Coffee will be served at the meeting venue before the meeting at 9:00 a.m.
(EET).

In Helsinki, 27 February 2026
TERVEYSTALO PLC
The Board of Directors

Terveystalo in brief

Terveystalo is the largest private healthcare service provider in Finland in
terms of revenue and one of the leading occupational health providers in both
Finland and Sweden.

We aim to create seamless, compassionate, and effective healthcare of the
future. We offer comprehensive primary care, specialised care, and well-being
services for corporate clients, insurance companies, consumers and public-sector
customers. Terveystalo's digital appointments are available anytime, anywhere,
24/7. The Terveystalo app has around 2.7 million registered users. We provide
services through our extensive network of clinics and hospitals across Finland.
In Sweden, we offer preventive occupational health services through our
subsidiary, Feelgood.

In 2025, Terveystalo served approximately 2.1 million individual customers, and
there were around 7.2 million customer visits in Finland.  Terveystalo employs
around 14,400 professionals in healthcare and other fields.

Terveystalo is listed on Nasdaq Helsinki and has a strong Finnish ownership
base. www.terveystalo.com

Attachments: